Multiple myeloma is the second most common hematological neoplasm that also affects young patients. The progression-free survival after autologous stem cell transplant has improved with the introduction of several novel agents such as lenalidomide, which may, however, increase the risk of adverse events.

Guerrini, S., Bucalossi, A., CIOFFI SQUITIERI, N., Mazzei, F.G., Volterrani, L., Mazzei, M.A. (2016). Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma. TUMORI, 102(Suppl. 2) [10.5301/tj.5000392].

Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma

GUERRINI, SUSANNA;CIOFFI SQUITIERI, NEVADA;VOLTERRANI, LUCA;MAZZEI, MARIA ANTONIETTA
2016-01-01

Abstract

Multiple myeloma is the second most common hematological neoplasm that also affects young patients. The progression-free survival after autologous stem cell transplant has improved with the introduction of several novel agents such as lenalidomide, which may, however, increase the risk of adverse events.
Guerrini, S., Bucalossi, A., CIOFFI SQUITIERI, N., Mazzei, F.G., Volterrani, L., Mazzei, M.A. (2016). Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma. TUMORI, 102(Suppl. 2) [10.5301/tj.5000392].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1008938
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo